Detalhe da pesquisa
1.
Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial.
Ann Intern Med
; 177(4): 449-457, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38560901
2.
Immunophenotypic assessment of clonal plasma cells and B-cells in bone marrow and blood in the diagnostic classification of early stage monoclonal gammopathies: an iSTOPMM study.
Blood Cancer J
; 13(1): 182, 2023 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38072838
3.
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies.
Blood Cancer J
; 11(5): 94, 2021 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34001889
4.
Correction: Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies.
Blood Cancer J
; 13(1): 39, 2023 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36935437